Pharming Group/$PHAR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pharming Group
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Ticker
$PHAR
Sector
Primary listing
Employees
407
Headquarters
Website
Pharming Group Metrics
BasicAdvanced
$927m
794.41
$0.02
0.12
-
Price and volume
Market cap
$927m
Beta
0.12
52-week high
$21.34
52-week low
$8.69
Average daily volume
14k
Financial strength
Current ratio
2.63
Quick ratio
2.049
Long term debt to equity
40.177
Total debt to equity
43.205
Interest coverage (TTM)
4.20%
Profitability
EBITDA (TTM)
42.282
Gross margin (TTM)
88.14%
Net profit margin (TTM)
3.34%
Operating margin (TTM)
9.44%
Effective tax rate (TTM)
38.57%
Revenue per employee (TTM)
$910,000
Management effectiveness
Return on assets (TTM)
4.89%
Return on equity (TTM)
5.04%
Valuation
Price to earnings (TTM)
794.41
Price to revenue (TTM)
24.823
Price to book
3.12
Price to tangible book (TTM)
6.08
Price to free cash flow (TTM)
164.594
Free cash flow yield (TTM)
0.61%
Free cash flow per share (TTM)
0.079
Growth
Revenue change (TTM)
15.21%
Earnings per share change (TTM)
-176.69%
3-year revenue growth (CAGR)
22.39%
10-year revenue growth (CAGR)
39.77%
3-year earnings per share growth (CAGR)
66.89%
10-year earnings per share growth (CAGR)
-7.16%
Pharming Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pharming Group stock?
Pharming Group (PHAR) has a market cap of $927M as of May 15, 2026.
What is the P/E ratio for Pharming Group stock?
The price to earnings (P/E) ratio for Pharming Group (PHAR) stock is 794.41 as of May 15, 2026.
Does Pharming Group stock pay dividends?
No, Pharming Group (PHAR) stock does not pay dividends to its shareholders as of May 15, 2026.
When is the next Pharming Group dividend payment date?
Pharming Group (PHAR) stock does not pay dividends to its shareholders.
What is the beta indicator for Pharming Group?
Pharming Group (PHAR) has a beta rating of 0.12. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.